CAROLYN HULL: Open Payments
NPI 1578956058 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 34 payments from 17 companies in 2025. Trend: 2023 $458 · 2024 $585 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $145 |
| Otsuka America Pharmaceutical, Inc. | 3 | $86 |
| Fresenius USA Marketing, Inc. | 4 | $79 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $38 |
| Novo Nordisk Inc | 1 | $30 |
| Vifor Pharma, Inc. | 1 | $28 |
| Travere Therapeutics, Inc. | 2 | $24 |
Products named: TAVNEOS, JYNARQUE, VELPHORO, JARDIANCE, BENLYSTA, KRYSTEXXA, Fabhalta, Rivfloza.
Industry payments across NC — which companies pay providers there.
